Erectile dysfunction

Journal of Urology

Volumn 175, Issue 3 SUPPL., 2006, Pages

  Burnett, Arthur L ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Impotence; Penile erection; Penis; Phosphodiesterase V

Indexed keywords

ORGANIC NITRATE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; VARDENAFIL;

ANDROGEN THERAPY; BACKACHE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG POTENTIATION; DRUG PROTEIN BINDING; DYSPEPSIA; ERECTILE DYSFUNCTION; FLU LIKE SYNDROME; FLUSHING; HEADACHE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC OPTIC NEUROPATHY; MYALGIA; NOSE CONGESTION; PAINFUL ERECTION; PATHOPHYSIOLOGY; PENILE SWELLING; PENIS PROSTHESIS; PRIAPISM; PRIORITY JOURNAL; REVIEW; RHINITIS; RISK FACTOR; SEXUAL DYSFUNCTION; SIDE EFFECT; SINUSITIS; SKIN DISCOMFORT; TACHYPHYLAXIS; TREATMENT PLANNING; VASODILATATION; VISUAL DISORDER;

EID: 31744437406     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00309-5     Document Type: Article

References (56)

1. NIH Consensus Conference ImpotenceNIH Consensus Development Panel on Impotence JAMA 270 1993 83
2. H. Padma-Nathan Diagnostic and treatment strategies for erectile dysfunction: the 'Process of Care' model: University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School Int J Impot Res 12 suppl. 2000 S119
3. D.K. Montague, J.P. Jarow, G.A. Broderick, R.R. Dmochowski, J.P. Heaton, T.F. Lue Erectile dysfunction guideline update panel, chapter 1 the management of erectile dysfunction-an AUA update J Urol 174 2005 230
4. E.O. Laumann, A. Paik, R.C. Rosen Sexual dysfunction in the United States prevalence and predictors JAMA 281 1999 537
5. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study J Urol 151 1994 54
6. A. Martin-Morales, J.J. Sanchez-Cruz, D.T. Saenz, L. Rodriguez-Vela, J.F. Jimenez-Cruz, R. Burgos-Rodriguez Prevalence and independent risk factors for erectile dysfunction in Spain results of the Epidemiologia de la Disfuncion Erectil Masculina Study J Urol 166 2001 569
7. M. Braun, G. Wassmer, T. Klotz, B. Reifenrath, M. Mathers, U. Engelmann Epidemiology of erectile dysfunction results of the 'Cologne Male Survey ' Int J Impot Res 12 2000 305
8. M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh Hypertension is associated with severe erectile dysfunction J Urol 164 2000 1188
9. S.E. Rosas, M. Joffe, E. Franklin, B.L. Strom, W. Kotzker, C. Brensinger Prevalence and determinants of erectile dysfunction in hemodialysis patients Kidney Int 59 2001 2259
10. T.F. Lue Erectile dysfunction N Engl J Med 342 2000 1802
11. G. Jackson Erectile dysfunction-the right to be treated Int J Clin Pract 53 1999 323
12. D. Ralph, T. McNicholas UK management guidelines for erectile dysfunction BMJ 321 2000 499
13. W. Schrooten, R. Colebunders, M. Youle, G. Molenberghs, N. Dedes, G. Koitz Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment AIDS 15 2001 1019
14. R.W. Lewis Epidemiology of erectile dysfunction Urol Clin North Am 28 2001 209
15. H.G. Nurnberg, P.L. Hensley, A.J. Gelenberg, M. Fava, J. Lauriello, S. Paine Treatment of antidepressant-associated sexual dysfunction with sildenafil a randomized controlled trial JAMA 289 2003 56
16. R. Shabsigh, L.T. Klein, S. Seidman, S.A. Kaplan, B.J. Lehrhoff, J.S. Ritter Increased incidence of depressive symptoms in men with erectile dysfunction Urology 52 1998 848
17. R.C. Rosen Psychogenic erectile dysfunction. Classification and management Urol Clin North Am 28 2001 269
18. C.A. Derby, B.A. Mohr, I. Goldstein, H.A. Feldman, C.B. Johannes, J.B. McKinlay Modifiable risk factors and erectile dysfunction can lifestyle changes modify risk? Urology 56 2000 302
19. H.A. Feldman, C.B. Johannes, C.A. Derby, K.P. Kleinman, B.A. Mohr, A.B. Araujo Erectile dysfunction and coronary risk factors prospective results from the Massachusetts male aging study Prev Med 30 2000 328
20. T.A. Miller Diagnostic evaluation of erectile dysfunction Am Fam Physician 61 2000 95
21. K.M. Azadzoi, I. Goldstein, M.B. Siroky, A.M. Traish, R.J. Krane, I. Saenz de Tejada Mechanisms of ischemia-induced cavernosal smooth muscle relaxation impairment in a rabbit model of vasculogenic erectile dysfunction J Urol 160 1998 2216
22. F.E. Kaiser, S.P. Viosca, J.E. Morley, A.D. Mooradian, S.S. Davis, S.G. Korenman Impotence and aging clinical and hormonal factors J Am Geriatr Soc 36 1988 511
23. K.T. McVary, S. Carrier, H. Wessells Smoking and erectile dysfunction evidence based analysis J Urol 166 2001 1624
24. J. Chun, C.C. Carson III Physician-patient dialogue and clinical evaluation of erectile dysfunction Urol Clin North Am 28 2001 249
25. F. Sommer, U. Schwarzer, T. Klotz, H.P. Caspers, G. Haupt, U. Engelmann Erectile dysfunction in cyclists Is there any difference in penile blood flow during cycling in an upright versus a reclining position? Eur Urol 39 2001 720
26. J.H. Romeo, A.D. Seftel, Z.T. Madhun, D.C. Aron Sexual function in men with diabetes type 2 association with glycemic control J Urol 163 2000 788
27. M. Cherington Hazards of bicycling from handlebars to lightning Semin Neurol 20 2000 247
28. V.S. Ricchiuti, C.A. Haas, A.D. Seftel, T. Chelimsky, I. Goldstein Pudendal nerve injury associated with avid bicycling J Urol 162 1999 2099
29. American Association of Clinical Endocrinologists Medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction a couple's problem-2003 update Endocr Pract 9 2003 77
30. A. Morales, J.P. Heaton Hormonal erectile dysfunction. Evaluation and management Urol Clin North Am 28 2001 279
31. A.M. Johri, J.P. Heaton, A. Morales Severe erectile dysfunction is a marker for hyperprolactinemia Int J Impot Res 13 2001 176
32. L. Tiefer, D. Schuetz-Mueller Psychological issues in diagnosis and treatment of erectile disorders Urol Clin North Am 22 1995 767
33. R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, B.M. Pena Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int J Impot Res 11 1999 319
34. R.F. DeBusk Evaluating the cardiovascular tolerance for sex Am J Cardiol 86 2000 51F
35. I. Eardley, P. Ellis, M. Boolell, M. Wulff Onset and duration of action of sildenafil for the treatment of erectile dysfunction Br J Clin Pharmacol 53 suppl. 2002 61S
36. S.A. Ballard, C.J. Gingell, K. Tang, L.A. Turner, M.E. Price, A.M. Naylor Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes J Urol 159 1998 2164
37. M. Boolell, M.J. Allen, S.A. Ballard, S. Gepi-Attee, G.J. Muirhead, A.M. Naylor Sildenafil an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction Int J Impot Res 8 1996 47
38. Cialis® package insert 2005 Lilly ICOS LLC Indianapolis
39. Levitra® package insert 2005 GlaxoSmithKline Research Triangle Park
40. Viagra® package insert 2005 Pfizer New York
41. A.R. McCullough, J.H. Barada, A. Fawzy, A.T. Guay, D. Hatzichristou Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction Urology 60 2002 28
42. A.T. Guay, J.B. Perez, J. Jacobson, R.A. Newton Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors J Androl 22 2001 793
43. A. Morales, C. Gingell, M. Collins, P.A. Wicker, I.H. Osterloh Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction Int J Impot Res 10 1998 69
44. W.J. Hellstrom, M. Gittelman, G. Karlin, T. Segerson, M. Thibonnier, T. Taylor Vardenafil for treatment of men with erectile dysfunction efficacy and safety in a randomized, double-blind, placebo-controlled trial J Androl 23 2002 763
45. R. El-Galley, H. Rutland, R. Talic, T. Keane, H. Clark Long-term efficacy of sildenafil and tachyphylaxis effect J Urol 166 2001 927
46. W. Steers, A.T. Guay, A. Leriche, C. Gingell, T.B. Hargreave, P.J. Wright Assessment of the efficacy and safety of Viagra® (sildenafil citrate) in men with erectile dysfunction during long-term treatment Int J Impot Res 13 2001 261
47. R. Sadovsky, T. Miller, M. Moskowitz, G. Hackett Three-year update of sildenafil citrate (Viagra) efficacy and safety Int J Clin Pract 55 2001 115
48. M.L. Gonzalgo, M. Brotzman, B.J. Trock, A.M. Geringer, A.L. Burnett, J.P. Jarow Clinical efficacy of sildenafil citrate and predictors of long-term response J Urol 170 2003 503
49. R. Lewis Review of intraurethral suppositories and iontophoresis therapy for erectile dysfunction Int J Impot Res 12 suppl. 2000 S86
50. I. Goldstein, T.R. Payton, P.J. Schechter A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction Urology 57 2001 301
51. I. Goldstein Working Group for the Study of Central Mechanisms in Erectile Dysfunction Male sexual circuitry Sci Am 283 2000 70
52. T.F. Lue, R. Basson, R. Rosen, F. Giuliano, S. Khoury, F. Montorsi Second international consultation on sexual medicine sexual dysfunctions in men and women 2004 Health Publications Paris
53. A. Jardin, G. Wagner, S. Khouri, F. Giuliano, H. Padma-Nathan, R. Rosen Recommendations of the First International Consultation on Erectile Dysfunction Erectile Dysfunction 2000 Health Publication Ltd Plymouth, United Kingdom
54. H. Padma-Nathan, W.D. Steers, P.A. Wicker Sildenafil Study Group Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction a double-blind, placebo controlled study of 329 patients Int J Clin Pract 52 1998 375
55. G.B. Brock, C.G. McMahon, K.K. Chen, T. Costigan, W. Shen, V. Watkins Efficacy and safety of tadalafil for the treatment of erectile dysfunction results of integrated analyses J Urol 168 2002 1332
56. H. Porst, R. Rosen, H. Padma-Nathan, I. Goldstein, F. Giuliano, E. Ulbrich The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction the first at-home clinical trial Int J Impot Res 13 2001 192